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Abstract
Background: Triglycerides are reported to be positively associated with blood pressure (both systolic and diastolic).
However, in a previous study, we reported a significant positive association between triglycerides and circulating
CD34-positive cells (endothelial repair) among non-hypertensive, but not hypertensive, participants. Since hypertension
and endothelial dysfunction have a bi-directional association (vicious cycle), the status of circulating CD34-positive cells
may influence the association between triglycerides and hypertension.
Methods: Since antihypertensive medication use may influence results of the present study, we conducted a
cross-sectional study of 327 community dwelling elderly (aged 60–69 years) Japanese participants who were
not taking anti-hypertensive medication and who had participated in a general health check-up in 2013–2015.
Results: Participants were classified into two groups based on median values of circulating CD34-positive cells
(0.93 cells/μL). For participants with lower circulating CD34-positive cells (n = 165), a significant positive association
was seen between triglycerides and blood pressure, but not for participants with higher circulating CD34-positive cells
(n = 162). The multivariable standardized parameter estimates (β) and p values of systolic blood pressure and diastolic
blood pressure were 0.23 (p = 0.007) and 0.18 (p = 0.036) for participants with lower circulating CD34-positive cells and
0.08 (p = 0.409) and 0.03 (p = 0.786) for those with higher circulating CD34-positive cells.
Conclusion: A significant positive association between triglycerides and blood pressure exists among those with lower,
but not higher, circulating CD34-positive cells. The level of circulating CD34-positive cells acts as a determinant factor
for the association between triglycerides and blood pressure.
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Background
Triglycerides have been reported to be positively associ-
ated with systolic blood pressure and diastolic blood
pressure in a community-dwelling sample of Japanese
adults [1]. Since hypertension and endothelial dysfunc-
tion have a bi-directional association (vicious cycle) [2],
increased endothelial repair activity may have a benefi-
cial influence on preventing hypertension.
Participants with higher numbers of circulating CD34-
positive cells may exhibit greater endothelial repair activity
than those with lower circulating CD34-positive cells since
such cells play an important role in endothelial repair [3, 4].
Our previous study showing a significant positive associ-
ation between triglycerides and circulating CD34-positive
cells (endothelial repair) among non-hypertensive, but not
hypertensive, participants [5] partly supports a mechanism
where higher endothelial repair activity may have a benefi-
cial influence on preventing hypertension.
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On the other hand, high-density lipoprotein (HDL)
cholesterol from participants with cardiovascular disease
is reported to be lacking in endothelial anti-inflammatory
effects and does not stimulate endothelial repair [6]. In
addition, high-density HDL cholesterol is positively associ-
ated with hypertension in participants with higher level of
circulating CD34-positive cells [7] on the assumption that
they might have a higher risk of cardiovascular disease
which stimulates endothelial repair activity.
However, no studies have reported on the impact of
circulating CD34-positive cell levels on the association
between triglycerides and blood pressure.
Based on this mechanism, we hypothesized that tri-
glycerides would be positively associated with blood
pressure, but only in those with low levels of circulating
CD34-positive cells, since they should have lower endo-
thelial repair activity.
To clarify the association between triglycerides and
blood pressure (systolic and diastolic), we conducted a
cross-sectional study of 327 elderly men (aged 60–
69 years) who were not taking anti-hypertensive medica-
tion and who had participated in an annual health
check-up from 2013 to 2015.
Methods
Study population
The total number of male residents aged 60–69 in 2015
(estimated by the National Institute of Population and
Social Security Research in March 2013) was 3264 for
Goto city and 1010 for Saza town [8]. The study popula-
tion comprised 617 male residents aged 60–69 years from
Goto city and Saza town in the western part of Japan, who
underwent an annual medical check-up from 2013 to
2015 as recommended by the Japanese government.
To avoid the influence of anti-hypertensive medication,
participants on anti-hypertensive medication (n = 266)
were excluded. Additionally, to avoid the influence of
inflammatory disease and chronic disease (influence of
undernutrition), participants with high white blood cell
counts (≥ 10,000 cells/μL (n = 7)) and low body mass
index (BMI < 18.5 kg/m2) (n = 14) were excluded from the
analysis, as were persons with missing data (n = 3). The
remaining patients, comprising 327 men at a mean age of
64.9 years (standard deviation (SD) 2.7; range 60–69),
were enrolled in the study.
Data collection and laboratory measurements
Trained interviewers obtained information on medical
history. Current drinker (≥ 69 g/week) and current
smoker were defined as drinker and smoker.
Body weight and height of patients wearing light cloth-
ing were measured using an automatic body compos-
ition analyzer (BF-220; Tanita, Tokyo, Japan), and BMI
(kg/m2) was calculated. Fasting blood samples were
collected in a heparin sodium tube, an EDTA-2K tube,
and a siliconized tube. Fresh samples (within 24 h from
drawing) from the heparin sodium tube were used to de-
termine the number of CD34-positive cells. BD (Beckton
Dickinson Biosciences) Trucount™ technology, an accur-
ate and reproducible single platform assay cited in the
International Society of Hematotherapy and Graft
Engineering (ISHAGE) guidelines [9] and supported by
automated software on the BD FACSCant™ II system,
was used to measure circulating CD34-positive cells.
Samples from the EDTA-2K tube were used to measure
white blood cell count using an automated procedure at
SRL, Inc. (Tokyo, Japan). Serum triglycerides, serum
HDL-cholesterol, hemoglobin A1c (HbA1c), and serum
creatinine were measured using standard laboratory pro-
cedures at SRL, Inc. (Tokyo, Japan). Glomerular filtration
rate (GFR) was estimated by using an established method
recently proposed by a working group of the Japanese
Chronic Kidney Disease Initiative [10]. According to this
adaptation, GFR (ml/min/1.73 m2) = 194 × (serum creatin-
ine (enzyme method))−1.094 × (age)−0.287.
Statistical analysis
The median value for circulating CD34-positive cells
(0.93 cells/μL) was set as the cutoff point, and we di-
chotomized the study population by median value.
Characteristics of the study population stratified by
circulating CD34-positive cell levels were expressed as
mean ± standard deviation. Simple correlation analysis
and simple linear regression analysis for blood pressure
(systolic and diastolic) and other variables were calcu-
lated for total participants and stratified by circulating
CD34-positive cell levels. Multiple linear regression ana-
lyses were also performed to evaluate the same. Because
triglycerides had a skewed distribution based on evalu-
ation by the Kolmogorov-Smirnov test, logarithmic
transformation was performed for the simple correlation
analysis and linear regression analysis. All statistical ana-
lyses were performed with the SAS system for Windows
(version 9.4; SAS Inc., Cary, NC). Probability values of
less than 0.05 were considered to be statistically
significant.
Results
Among the whole study population, 165 participants
were categorized as having lower CD34-positive cells
(≤ 0.93 cells/μL) and 162 as higher CD34-positive
cells (> 0.93 cells/μL).
Characteristics of the study population based on circu-
lating CD34-positive cell levels are shown in Table 1.
Compared to participants with low CD34-positive cell
levels, those with high CD34-positive cell levels showed
significantly higher BMI, prevalence of overweight, and
triglyceride values, and significantly lower HDL
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cholesterol values. Since high BMI values are known
to be associated with hypertension [11], we conducted
further analyses and found that overweight partici-
pants (BMI ≥ 25 kg/m2) showed significantly higher
triglycerides (129 ± 61 mg/dL) and lower HDL choles-
terol (51.8 ± 9.4 mg/dL) compared to non-overweight
participants (108 ± 81 mg/dL), p = 0.037, and (59.0 ±
15.0 mg/dL), p < 0.001, respectively.
Table 2 shows a simple correlation analysis of blood
pressure and other variables.
For participants with lower CD34-positive cell
levels, a significant positive association was seen be-
tween triglycerides and systolic and diastolic blood
pressure, whereas no significant associations were
observed for participants with higher levels of CD34-
positive cells. The simple correlation coefficients and
p values of systolic blood pressure and diastolic blood
pressure for participants with lower CD34-positive
cell levels were 0.26 (p = 0.001) and 0.17 (p = 0.026),
respectively, and for participants with higher CD34-
positive cell levels were 0.003 (p = 0.962) and − 0.02
(p = 0.772), respectively.
Figure 1 shows the circulating CD34-positive cell
level-specific correlation between blood pressure and tri-
glycerides from a simple linear regression analysis. For
participants with lower circulating CD34-positive cells, a
significant positive association was seen between triglyc-
erides and systolic and diastolic blood pressure, whereas
no significant associations were observed for participants
with higher circulating CD34-positive cells. These corre-
lations remained unchanged even after further adjust-
ment for known cardiovascular risk factors (Table 3).
The multivariable standardized parameter estimates and
p values of triglycerides for systolic and diastolic blood
pressure were 0.23 (p = 0.007) and 0.18 (p = 0.036),
respectively, for lower circulating CD34-positive cells
and 0.08 (p = 0.409) and 0.03 (p = 0.786), respectively, for
higher circulating CD34-positive cells.
Since our previous study that reported an association be-
tween triglycerides and circulating CD34-postive cells did
not use the log transformation technique for triglycerides
[2], we performed further analyses without using log trans-
formation and found essentially the same associations. The
simple correlation coefficient (r) for systolic blood pressure
and triglycerides was r = 0.27 (p = 0.005) for participants
with lower CD34-positive cells and r = 0.07 (p = 0.351) for
subjects with higher CD34-positive cells; the simple correl-
ation coefficient (r) for diastolic blood pressure and triglyc-
erides was r = 0.16 (p = 0.040) for participants with lower
CD34-positive cells and r = 0.06 (p = 0.486) for participants
with higher CD34-positive cells. From a multivariable
linear regression model, the parameter estimate (Β) and
standardized parameter estimate (β) for systolic blood pres-
sure was Β = 0.09 and β = 0.24 (p = 0.004) for participants
with lower CD34-positive cells and Β = 0.03 and β = 0.16
(p = 0.072) for participants with higher CD34-positive cells;
the parameter estimate (Β) and standardized parameter es-
timate (β) for diastolic blood pressure was Β = 0.04 and β
= 0.16 (p = 0.049) for participants with lower CD34-
positive cells and Β = 0.01 and β = 0.12 (p = 0.182) for
participants with lower CD34-positive cells.
We also uncovered a significant association between
triglycerides and CD34-positive cell level on systolic
blood pressure and diastolic blood pressure, with p
values for the effect of this interaction of 0.011 and
0.049, respectively.
Discussion
The major findings of present study are that for par-
ticipants with lower circulating CD34-positive cells,
independent of known cardiovascular risk factors, tri-
glycerides are positively associated with blood pres-
sure, but not in participants with higher circulating
CD34-positive cells. The level of circulating CD34-
positive cells acts as a determinant factor for the
association between triglycerides and blood pressure.
A previous Japanese study of 567 men and 808 women
aged 19–90 years reported an independent positive asso-
ciation between triglycerides and systolic blood pressure
and diastolic blood pressure [1]. That study is partly
compatible with our results showing, independent of
known cardiovascular risk factors, a significant positive
association between triglycerides and systolic blood
Table 1 Characteristics of the study population based on levels
of circulating CD34-positive cells
CD34-positive cells p
Lower Higher
Circulating CD34 positive cells, cells/μL 0.63 ± 0.19 2.02 ± 1.82
No. of participants 165 162
Age, year 65.0 ± 2.6 64.9 ± 2.7 0.600
Systolic blood pressure, mmHg 131 ± 18 133 ± 18 0.312
Diastolic blood pressure, mmHg 79 ± 12 80 ± 12 0.403
BMI, kg/m2 22.6 ± 2.6 23.7 ± 2.7 < 0.001
Over weight (BMI ≥ 25 kg/m2), % 17.6 30.9 0.005
Drinker, % 43.6 45.1 0.796
Smoker, % 12.7 17.9 0.195
HDL, mg/dL 59 ± 13 55 ± 15 0.019
Triglycerides, mg/dL 95 ± 46 131 ± 96 < 0.001
HbA1c, % 5.6 ± 0.6 5.7 ± 0.7 0.159
Serum creatinine, mg/dL 0.85 ± 0.16 0.83 ± 0.14 0.183
GFR, mL/min/1.73m2 72.0 ± 13.3 73.8 ± 13.1 0.222
Values, mean ± standard deviation. Lower CD34-positive cells, ≤ 0.93 cells/μL.
Higher CD34-positive cells, > 0.93 cells/μL
BMI body mass index, HDL HDL cholesterol, HbA1c hemoglobin A1c, GFR
glomerular filtration rate
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Table 2 Simple correlation coefficient of blood pressure (systolic and diastolic) and other variables
Systolic blood pressure Diastolic blood pressure
CD34-positive cells CD34-positive cells
Total participants Lower Higher Total participants Lower Higher
No. of participants 327 165 162 327 165 162
Age 0.03 − 0.01 0.07 − 0.07 − 0.08 − 0.06
(0.586) (0.901) (0.357) (0.187) (0.278) (0.455)
BMI 0.17 0.20 0.13 0.22 0.25 0.18
(0.002) (0.009) (0.099) (< 0.001) (0.001) (0.022)
Drinker 0.14 0.14 0.14 0.04 0.02 0.07
(0.010) (0.073) (0.066) (0.441) (0.821) (0.391)
Smoker − 0.05 − 0.05 − 0.06 0.02 0.16 − 0.11
(0.344) (0.523) (0.425) (0.721) (0.046) (0.156)
HDL 0.05 − 0.02 0.12 0.04 − 0.03 0.12
(0.413) (0.837) (0.142) (0.438) (0.729) (0.126)
HbA1c 0.13 0.23 0.03 0.08 0.10 0.05
(0.023) (0.004) (0.691) (0.156) (0.181) (0.532)
GFR − 0.006 − 0.04 0.02 − 0.03 − 0.01 − 0.05
(0.910) (0.629) (0.809) (0.610) (0.897) (0.490)
Triglycerides 0.13 0.26 0.003 0.08 0.17 − 0.02
(0.019) (< 0.001) (0.962) (0.164) (0.026) (0.772)
Triglycerides are calculated in logarithm values. Lower CD34-positive cells, ≤ 0.93 cells/μL. Higher CD34-positive cells, > 0.93 cells/μL. The p values are enclosed
in parentheses
BMI body mass index, HDL high-density lipoprotein cholesterol, HbA1c hemoglobin A1c, GFR glomerular filtration rate
Triglycerides (logarithmic values)
Triglycerides (logarithmic values)
Lower Circulating CD34-positive cells 
Lower Circulating CD34-positive cells 
Higher Circulating CD34-positive cells 

















DBP = 4.97 × Log TG + 57.1
p=0.026
DBP = -0.52 × Log TG + 82.9
p=0.772
SBP= 11.0 × Log TG + 82.1
P<0.001




Fig. 1 Scatter plot of blood pressure (systolic and diastolic) and triglycerides
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pressure, but not diastolic blood pressure, in total
participants.
We found further evidence that circulating CD34-
positive cell levels may influence the association between
triglycerides and blood pressure, since triglycerides were
found to be positively associated with systolic and dia-
stolic blood pressure in participants with lower, but not
higher, circulating CD34-positive cells.
Hypertension and endothelial dysfunction have a bi-
directional association (vicious cycle) [2]. Since triglycer-
ides can become an independent risk factor for the early
development of atherosclerosis (endothelial dysfunction)
[12, 13], triglycerides may be positively associated with
blood pressure.
However, such positive associations were not observed
among participants with higher circulating CD34-
positive cells. Bone marrow-derived endothelial progeni-
tor cells such as CD34-positive cells have been reported
to play an important role in maintaining the vascular
endothelium [14, 15], and endothelial dysfunction has
been recognized as one of the initial mechanisms leading
to atherosclerosis (increased arterial stiffness) [16].
Therefore, increased levels of circulating CD34-positive
cells should have a beneficial effect in preventing athero-
sclerosis (endothelial dysfunction) in those where no sig-
nificant association exists between triglycerides and
hypertension. A previous study of 57 asymptomatic men
that reported an association between increased numbers
of circulating CD34-positive cells and a decrease in the
extent of subclinical atherosclerosis [17] might support
the above-mentioned mechanisms.
Although increased levels of circulating CD34-positive
cells should have a beneficial effect on the endothelium,
our present study showed essentially the same values for
blood pressure regardless of CD34-positive cell level.
Our previous study reported a positive association be-
tween BMI and circulating CD34-positive cell levels,
divided by median values of circulating CD34-positive
cells among the general population [2], as in the present
study. Since BMI is positively associated with hyperten-
sion [11], and hypertension participates in a vicious cycle
with endothelial dysfunction [2], overweight participants
(BMI ≥ 25 kg/m2) should have activated endothelial ac-
tivity, resulting in elevated circulating CD34-positive
Table 3 Multiple linear regression analysis of blood pressure (systolic and diastolic) with relevant factors adjusted for confounding
factors
Total participants CD34-positive cells
Lower Higher
Β β p Β β p Β β p
Systolic blood pressure
No. of participants 327 165 162
Age 0.37 0.05 0.333 − 0.03 − 0.004 0.960 0.72 0.11 0.180
BMI 1.13 0.17 0.004 1.06 0.15 0.061 1.23 0.18 0.031
Drinker 3.93 0.11 0.070 3.35 0.09 0.274 3.44 0.09 0.273
Smoker − 0.02 − 0.0005 0.993 1.15 0.02 0.793 − 1.05 − 0.02 0.790
HDL 0.21 0.16 0.013 0.15 0.11 0.196 0.25 0.20 0.036
HbA1c 2.78 0.10 0.066 6.01 0.20 0.009 0.49 0.02 0.809
GFR − 0.02 − 0.02 0.765 0.02 0.01 0.875 − 0.02 − 0.02 0.831
Triglycerides 4.80 0.13 0.035 9.61 0.23 0.007 2.67 0.08 0.409
Diastolic blood pressure
No. of participants 327 165 162
Age − 0.22 − 0.05 0.383 − 0.28 − 0.06 0.462 − 0.08 − 0.02 0.809
BMI 1.02 0.22 < 0.001 1.10 0.23 0.005 1.04 0.24 0.005
Drinker 0.39 0.02 0.790 0.015 0.001 0.994 0.25 0.01 0.903
Smoker 1.04 0.03 0.595 6.62 0.18 0.028 − 2.93 − 0.09 0.257
HDL 0.13 0.15 0.022 0.08 0.08 0.326 0.16 0.20 0.037
HbA1c 1.03 0.06 0.307 1.66 0.08 0.282 0.69 0.04 0.606
GFR − 0.03 − 0.03 0.535 0.04 0.04 0.625 − 0.07 − 0.08 0.333
Triglycerides 1.85 0.08 0.225 5.04 0.18 0.036 0.57 0.03 0.786
Triglycerides are calculated in logarithm values. Lower CD34-positive cells, ≤ 0.93 cells/μL. Higher CD34-positive cells, > 0.93 cells/μL
BMI body mass index, HDL high-density lipoprotein cholesterol, HbA1c hemoglobin A1c, GFR glomerular filtration rate, Β parameter estimate, β standardized
parameter estimate, p p factor for multivariable linear regression models
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cells. In our present study, overweight participants showed
significantly higher values for triglycerides and lower
values for HDL cholesterol compared to non-overweight
participants. Therefore, participants with higher CD34-
positive cells could have significantly higher triglycerides
and lower HDL cholesterol due to a higher prevalence of
being overweight. In fact, the present study found that
participants with higher CD34-positive cells show a sig-
nificantly higher prevalence of being overweight compared
to those with lower CD34-positive cells. Since higher BMI
is associated with hypertension [11], and HDL cholesterol
is reported to be positively associated with hypertension
in participants with higher, but not lower, circulating
CD34-positive cells [7], these factors might cause elevated
blood pressure values in participants with higher circulat-
ing CD34-positive cells. In addition to the influence of a
higher prevalence of being overweight, unlike HDL chol-
esterol from healthy participants, HDL cholesterol from
participants with stable cardiovascular disease or acute
coronary syndrome is reported to be lacking in endothelial
anti-inflammatory effects and does not stimulate endothe-
lial repair [6]. Therefore, participants with a high level of
CD34-positive cells should present with endothelial injury
similar to participants with stable cardiovascular disease
and acute coronary syndrome since endothelial repair ac-
tivity should be stimulated by endothelial injury.
Potential limitations of this study warrant consider-
ation. Although the level of circulating CD34-positive
cells significantly influences the association between tri-
glycerides and blood pressure, no data on the evaluation
of endothelial function was available. Further analyses
that include endothelial function-related data such as
flow-mediated dilation (FMD) will be necessary. Add-
itionally, because this was a cross-sectional study, causal
relationships were not able to be established.
Conclusion
In conclusion, for participants with lower circulating
CD34-positive cells, independent of known cardiovascu-
lar risk factors, triglycerides are positively associated
with blood pressure, but not in participants with higher
circulating CD34-positive cells. The level of circulating
CD34-positive cells acts as a determinant factor for the
association between triglycerides and blood pressure.
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